logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Expert Opinion on Drug Safety 封面图

Expert Opinion on Drug Safety

IF3.1
论文数2770
被引数5299
期刊论文 2770
发表时间
delete
Long-term safety of treatment of hemophilia A: a comprehensive review血友病A的治疗长期安全性：一项全面综述
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-09-30
delete0
PREAI
deleteJohnny Mahlangu
delete分享
delete收藏
Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT甲氨蝶呤与佩格洛替卡塞联用治疗未控制痛风患者的耐受性：镜像随机对照试验结果概述
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-09-16
delete0
PREAI
deleteVinicius Domingues; Abdul Abdellatif; Alexis Woods; Quinnie Yang; Michael E. Weinblatt; Junzhi Ji; Brad Marder; Brian LaMoreaux
delete分享
delete收藏
A safety review of jak inhibitors for managing alopecia areata斑秃管理的JAK抑制剂安全性综述
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-09-15
delete0
PREAI
deleteKanchalit Thanomkitti; Sofia Spagnolini; Antonella Tosti
delete分享
delete收藏
Psychedelics in psychiatry: comparative effectiveness, implementation, commercialization and safety lessons learned from intranasal esketamine精神病学中的致幻药物：从鼻腔内 esketamine 中获得的比较有效性、实施、商业化和安全性经验教训
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-09-01
delete0
deleteOAAI
deleteRoger S. McIntyre
delete分享
delete收藏
Safety of treatments for children with functional constipation功能性便秘儿童的治疗安全性
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-08-24
delete0
PREAI
deleteTirza M. van Os; Megan A. Read; Richard J. Wood; Carlo Di Lorenzo; Marc A. Benninga; Peter L. Lu
delete分享
delete收藏
Lesser-known medication safety considerations in sickle cell disease镰状细胞病中鲜为人知的用药安全考量
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-08-19
delete0
deleteOAAI
deleteNajbah Galadanci; Julie Kanter
delete分享
delete收藏
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis接受免疫检查点抑制剂治疗的癌症患者中的肌炎：ARON-MOUSEION-017系统评价与荟萃分析
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-08-14
delete0
PREAI
deleteElsa Vitale; Gerardo Cazzato; Lorenza Maistrello; Mario Della Mura; Mauro Francesco Pio Maiorano; Francesco Ciccimarra; Oronzo Brunetti; Concetta Calabrò; Brigida Anna Maiorano; Fernando Sabino Marques Monteiro; Enes Erul; Francesco Massari; Alessandro Rizzo; Matteo Santoni
delete分享
delete收藏
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials双TIGIT和PD-L1阻断剂联合替拉戈鲁单抗和阿替利珠单抗在实体瘤中的安全性分析：一项随机对照试验的系统评价和荟萃分析
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-08-12
delete0
deleteOAAI
deleteZaher Mutaz Ashour; Mus’ab Theeb Mustafa; Osama Wadah Rammaha; Abdallah Moh’d Said Hamdan; Yihea Mohammad Al-Mashaqbah; Abdallah Yaser Alasmar; Lou’y Ahmed Al-Rabaeh; Mohammad AlElaimat; Ayham Omar Khalifah; Omar Jamal Ramadan; Aws Khalid Abushanab; Abdulqadir J. Nashwan
delete分享
delete收藏
Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis膝关节骨关节炎患者关节内皮质类固醇注射的长期疗效与安全性
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-21
delete0
deleteOAAI
deleteAricia J. Thirumaran; David J. Hunter
delete分享
delete收藏
Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies中重度特应性皮炎患者中Janus激酶抑制剂的用药安全性：一项观察性研究的系统评价与Meta分析
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-16
delete0
PREAI
deleteMei Li; Jianing Ni; Lian Zhang; Can Chen; Jingjing Ye; Ninggang Chen
delete分享
delete收藏
Exploring the safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy探索房颤患者临床复杂表型中直接口服抗凝剂的安全性与有效性：重点关注衰弱、多病共存和多重用药
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-12
delete0
PREAI
deletePanteleimon E. Papakonstantinou; Gregory Y. H. Lip
delete分享
delete收藏
Trigger tool methodologies in hospital settings: reappraising their role in pharmacovigilance and digital safety surveillance医院环境中的触发工具方法：重新评估其在药物警戒和数字安全监测中的作用
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-07-10
delete0
PREAI
deleteMarija Ilic; Dejana Krajacic; Marina Blagojevic; Milica Paut Kusturica; Jovanka Kolarovic; Djendji Siladji; Nebojsa Stilinovic; Aleksandar Raskovic
delete分享
delete收藏
Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability抗胆碱能药物会加速ALS进展吗？药物安全性与疾病易感性的批判性视角
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-30
delete0
PREAI
deleteTiffany R. Price; Chia-Yuan Chang; Kirya Skinner; Michael Dinneny; Parmida Nafezi; Lisa Kuramoto; Mary A. De Vera; Neil R. Cashman; Jacquelyn J. Cragg
delete分享
delete收藏
Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy替普鲁单抗(trbw)的安全概况，其为美国食品药品监督管理局(FDA)批准用于治疗甲状腺相关眼病的首个且唯一的治疗方法
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-24
delete0
PREAI
deleteTerry J. Smith
delete分享
delete收藏
A systematic review and meta-analysis of safety and efficacy parameters of sotatercept in the therapy of pulmonary arterial hypertensionsotatercept在肺动脉高压治疗中的安全性和有效性参数的系统评价与Meta分析
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-09
delete0
PREAI
deleteSiddhartha Dutta; Rima Shah; Shubha Singhal; Mamta Singh; Sagar Dholariya; Shalini Chawla; Chandan Katoch
delete分享
delete收藏
Tirzepatide data: safety first is safety always!替尔泊肽数据：安全第一，永远如此！
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-06-02
delete0
PREAI
deleteMiodrag Janić; Syed Arman Rabbani; Mohamed El-Tanani; Imran Rangraze; Andrej Janež; Viviana Maggio; Manfredi Rizzo
delete分享
delete收藏
An update on the safety of biologics for the treatment of psoriasis关于生物制剂治疗银屑病安全性的最新进展
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-22
delete0
PREAI
deleteVictoria McGuirt; Hiral Patel; Maia Davis; Steven Feldman
delete分享
delete收藏
Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury曲妥珠单抗及其抗体偶联物相关肝损伤的最新进展
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-17
delete0
PREAI
deleteLiyi Chen; Guo-Hui Li; Chun-Yu Li
delete分享
delete收藏
Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies曲妥珠单抗的长期心脏毒性结局及新型HER2靶向疗法的心脏安全性
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-04
delete0
PREAI
deleteSelin Akturk Esen; Dogan Uncu; Mehmet Ali Nahit Sendur
delete分享
delete收藏
Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations抗IL-5化合物在嗜酸性哮喘治疗中的安全性，重点关注特殊人群
deleteExpert Opinion on Drug Safety
IF3.1
delete2026-05-01
delete0
PREAI
deleteCaminati, Marco; Gagliani, Claudia; Bondi, Benedetta; Bagnasco, Diego; Vijverberg, Susanne J. H.; Zurlo, Marco; Maule, Matteo; Principe, Stefania
delete分享
delete收藏